The impact of Initial Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: a French prospective cohort.

F. Couturaud (Brest, France), C. Orione (Brest, France), C. Tromeur (Brest, France), P. Le Floch (Brest, France), P. Salaun (Brest, France), C. Leroyer (Brest, France)

Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism
Session: From diagnosis to management of pulmonary embolism
Session type: Oral Presentation
Number: 4978
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Couturaud (Brest, France), C. Orione (Brest, France), C. Tromeur (Brest, France), P. Le Floch (Brest, France), P. Salaun (Brest, France), C. Leroyer (Brest, France). The impact of Initial Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: a French prospective cohort.. 4978

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism: results from a prospective cohort study
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020


Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Rivaroxaban for treatment of venous thromboembolism. A real-life perspective in 103 patients
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies.
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021



Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017


Long-term data from the Swiss pulmonary hypertension registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Clinical phenotypes in pulmonary emboli identified by cluster analysis
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

Isolated hypocapnia: A sign not to be neglected
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Clinical and Epidemiological Features of Tumor and Non-tumor Patients Complicated with Pulmonary Embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017


Clinical and Epidemiological Features of Lung Cancer Complicated with Pulmonary Embolism
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017

Clinical Risk Stratification of Pulmonary Embolism to Support the Development of a Pulmonary Embolism Response Team (PERT) at a Tertiary Referral Hospital.
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020


Epoprostenol dosing by concomitant therapies in the PROSPECT registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Pulmonary arterial hypertension – A single-centre experience
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Prognosis factors of recurrent pulmonary thromboembolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

An overview of thrombolytic treatment for pulmonary embolism: A single center experience
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Outcomes in embolisations of pulmonary arterio-venous malformations
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Do persistent perfusion defects predict late recurrences in pulmonary embolism?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Prognostic value of outcome variables at follow-up in patients with PAH
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014